Browse Title Index
| Issue | Title | |
| Vol 6, No 2 (2015) | Deep molecular response after 3rd-line dasatinib treatment in patient with chronic myelogenous leukemia in chronic phase | Abstract PDF (Polish) HTML (Polish) |
| Maria Lewandowska, Michał Gniot, Błażej Ratajczak, Małgorzata Jarmuż-Szymczak, Krzysztof Lewandowski | ||
| Vol 2, No 1 (2011) | Deferasirox (Exjade®) as iron chelator in children | Abstract PDF (Polish) |
| Michał Matysiak | ||
| Vol 3, No 4 (2012) | Deregulation of BCL2 family proteins in B-cell lymphomas — molecular, pathogenetic, clinical and therapeutic implications | Abstract PDF (Polish) |
| Przemysław Kiliszek, Przemysław Juszczyński | ||
| Vol 3, No 4 (2012) | Deregulation of MYC transcription factor in lymphoid tumors — molecular, pathogenetic, clinical and therapeutic implications | Abstract PDF (Polish) |
| Tomasz Sewastianik, Monika Prochorec-Sobieszek, Przemysław Juszczyński | ||
| Vol 1, No 3 (2010) | Diagnosis and monitoring of chronic myeloid leukemia therapy | Abstract PDF (Polish) |
| Tomasz Sacha, Kajetana Foryciarz | ||
| Vol 13, No 2 (2022) | Diagnosis and treatment of immune thrombocytopenia in Poland | Abstract PDF |
| Piotr Małecki, Sebastian Grosicki | ||
| Vol 8, No 2 (2017) | Diagnosis and treatment of patients with diffuse large B-cell lymphoma | Abstract PDF (Polish) HTML (Polish) |
| Krzysztof Warzocha, Bartosz Puła | ||
| Vol 8, No 3 (2017) | Diagnosis and treatment of patients with Hodgkin lymphoma | Abstract PDF (Polish) HTML (Polish) |
| Tomasz Wróbel, Bartosz Puła | ||
| Vol 8, No 3 (2017) | Diagnosis and treatment of patients with mature T-cell and NK-cell neoplasms | Abstract PDF (Polish) HTML (Polish) |
| Krzysztof Warzocha, Bartosz Puła | ||
| Vol 11, No 2 (2020) | Diagnosis and treatment of systemic mastocytosis — experts’ statement | Abstract PDF (Polish) |
| Marek Hus, Aneta Szudy-Szczyrek, Grzegorz Helbig, Tomasz Sacha, Andrzej Mital, Bożena Katarzyna-Budziszewska, Monika Prochorec-Sobieszek, Krystyna Gałązka | ||
| Vol 1, No 1 (2010) | Diagnosis of the prolonged activated partial thromboplastin time (aPTT) | Abstract PDF (Polish) |
| Krzysztof Chojnowski, Maria Podolak-Dawidziak, Jerzy Windyga | ||
| Vol 12, No 2 (2021) | Diagnostic and therapeutic recommendations of the Polish Society of Haematologists and Transfusiologists and Polish Adult Leukemia Group-CLL for chronic lymphocytic leukemia in 2021 | Abstract PDF |
| Iwona Hus, Krzysztof Giannopoulos, Krzysztof Jamroziak, Jerzy Błoński, Dariusz Wołowiec, Jacek Roliński, Piotr Smolewski, Tadeusz Robak | ||
| Vol 4, No 2 (2013) | Diagnostic difficulties in a congenital hemolytic anemia | Abstract PDF (Polish) HTML (Polish) |
| Ewa Mendek-Czajkowska, Justyna Spychalska, Krzysztof Warzocha | ||
| Vol 9, No 3 (2018) | Diagnostics and treatment of AL amyloidosis | Abstract PDF (Polish) |
| Krzysztof Jamroziak, Paolo Milani, Bartosz Puła, Sonia Dębek, Giovanni Palladini | ||
| Vol 3, No 3 (2012) | Differential diagnosis of essential thrombocythemia | Abstract PDF (Polish) |
| Monika Prochorec-Sobieszek, Anna Szumera-Ciećkiewicz, Olga Szymańska-Giemza | ||
| Vol 1, No 1 (2010) | Differential diagnosis of Philadelphia-negative chronic myeloproliferative neoplasms | Abstract PDF (Polish) |
| Krzysztof Lewandowski | ||
| Vol 11, No 4 (2020) | Difficulties in the management of a patient with acute myeloid leukaemia and high mutant allelic ratio FLT3-ITD — refractoriness to the standard induction therapy along with midostaurin | Abstract PDF (Polish) |
| Elżbieta Patkowska, Joanna Sawczuk-Chabin, Iwona Solarska, Katarzyna Borg, Ewa Lech-Marańda | ||
| Vol 12, Supp. D (2021) | Difficulties in the management of a patient with acute myeloid leukaemia and high mutant allelic ratio FLT3-ITD — refractoriness to the standard induction therapy along with midostaurin | Abstract PDF |
| Elżbieta Patkowska, Joanna Sawczuk-Chabin, Iwona Solarska, Katarzyna Borg, Ewa Lech-Marańda | ||
| Vol 4, No 2 (2013) | Diffuse large B-cell lymphoma — management recommendations of the Institute of Hematology and Transfusion Medicine | Abstract PDF (Polish) HTML (Polish) |
| Krzysztof Warzocha | ||
| Vol 11, Supp. A (2020) | Discontinuation of nilotinib treatment in a patient with chronic myelogenous leukemia and thrombocytopenia induced by imatinib | Abstract PDF (Polish) |
| Olga Grzybowska-Izydorczyk, Joanna Góra-Tybor | ||
| Vol 9, No 3 (2018) | Doxycycline in the treatment of systemic amyloidosis with cardiac involvement. | Abstract PDF (Polish) |
| Justyna Łyczkowska-Piotrowska, Aleksander Salomon-Perzyński, Agnieszka Końska, Krzysztof Jamroziak | ||
| Vol 6, No 3 (2015) | Drugs for treating patients with chronic lymphocytic leukemia with FDA granted ‘Breakthrough Therapy Status’ — implications for patients | Abstract PDF HTML |
| Rafał Zyśk, Dariusz Wołowiec | ||
| Vol 3, No 2 (2012) | Durable primary immune thrombocytopenia remission after transient romiplostim treatment | Abstract PDF (Polish) |
| Elżbieta Patkowska, Ewa Lech-Marańda, Krzysztof Warzocha | ||
| Vol 10, Supp. A (2019) | Długoterminowa skuteczność azacytydyny u chorej z ostrą białaczką szpikową na podłożu zmian dysplastycznych | Abstract PDF (Polish) |
| Marcin Wójtowicz | ||
| Vol 10, Supp. A (2019) | Długoterminowe leczenie azacytydyną chorego na zespół mielodysplastyczny wyższego ryzyka | Abstract PDF (Polish) |
| Grzegorz Charliński, Weronika Piszczek, Weronika Piszczek | ||
| 101 - 125 of 543 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl
